Back to search

Introduction to Antifungal Drugs

Data up to Jan 2025

Published2000
Citations270
References26

Total Citations Per Year

Abstract

References (26)

Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

1999 • 1,184 citations

Amphotericin B: 30 Years of Clinical Experience

1990 • 1,011 citations

Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

1997 • 862 citations

Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome

1997 • 801 citations

Fluconazole

1990 • 658 citations

Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases

1998 • 631 citations

Lipid Formulations of Amphotericin B: Recent Progress and Future Directions

1996 • 400 citations

Lipid Formulations of Amphotericin B: Clinical Efficacy and Toxicities

1998 • 396 citations

Itraconazole

1989 • 341 citations

Randomized, Double‐Blind Clinical Trial of Amphotericin B Colloidal Dispersion vs. Amphotericin B in the Empirical Treatment of Fever and Neutropenia

1998 • 301 citations

Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis

1997 • 288 citations

Systemic Antifungal Agents

1998 • 284 citations

Evolving Role of Flucytosine in Immunocompromised Patients: New Insights into Safety, Pharmacokinetics, and Antifungal Therapy

1992 • 228 citations

Do In Vitro Susceptibility Data Predict the Microbiologic Response to Amphotericin B? Results of a Prospective Study of Patients withCandidaFungemia

1998 • 222 citations

Amphotericin B Lipid Complex Compared with Amphotericin B in the Treatment of Cryptococcal Meningitis in Patients with AIDS

1996 • 201 citations

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

1995 • 200 citations

Prevention of Amphotericin B—Induced Renal Impairment

1988 • 195 citations

Fluconazole

1995 • 193 citations

Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis.

1997 • 163 citations

Clinical Infectious Diseases

1998 • 155 citations

Pretreatment Regimens for Adverse Events Related to Infusion of Amphotericin B

1995 • 116 citations

Treatment of Invasive Fungal Infections in Renally Impaired Patients with Amphotericin B Colloidal Dispersion

1998 • 59 citations

Randomized, double-blind trial of 1- versus 4-hour amphotericin B infusion durations

1990 • 57 citations

Use of Azoles for Systemic Antifungal Therapy

1997 • 51 citations

Rapid intravenous infusion of amphotericin B: A pilot study

1992 • 47 citations

Overview of Oral Azole Drugs as Systemic Antifungal Therapy

1997 • 18 citations

Cited By (0)

Loading...